Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice
about
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodiesType 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" DiseaseRole of B cells in tolerance inductionResponse to rituximab in patients with rheumatoid arthritis in different compartments of the immune system.Restoring immune tolerance in neuromyelitis optica: Part IIB cells responses and cytokine production are regulated by their immune microenvironmentB cell depletion reduces the number of autoreactive T helper cells and prevents glucose-6-phosphate isomerase-induced arthritisActive chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis.B cells limit repair after ischemic acute kidney injury.Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effectsB-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.B cell depletion reduces the development of atherosclerosis in mice.Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activityRituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-κB.Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microfloraEffect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice.IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse modelB lymphocytes: how they develop and function.Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsAcute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in miceChallenges in the pursuit of immune tolerance.Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.Cellular requirements for diabetes induction in DO11.10xRIPmOVA mice.Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model.B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance TreatmentThe tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markersB Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.Mechanisms of B cell autoimmunity in SLE.Enhanced renewal of regulatory T cells in relation to CD4(+) conventional T lymphocytes in the peripheral compartment.Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor AnalysisAutoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus
P2860
Q24598772-1E49F7C3-1F6C-485D-A2BB-58CAD6F7BC67Q26740115-43CBD030-54B5-453B-8BF2-C40A65F9EFEEQ26824451-47A908D1-7E2C-4FBE-8CFB-98A5A35417D5Q27692640-6785FDBB-65D2-4E39-9A9F-2FA3A5B70F52Q28070136-B921098E-87DE-4D74-874E-31E008635FEBQ28083170-4113C1B7-C0AC-46D1-9F71-D086CA24E727Q28740546-37444366-E3FE-4A8F-A5F6-ED4D09949532Q31087724-0A3093A1-D892-4BD5-A4DA-CAB8331CCBE7Q33402209-74E33B9B-899A-4FDE-99F2-0E4958AD092FQ33694092-A37D9112-98BA-44CE-9AF1-4D9840A5F50BQ33721777-461723E8-021E-48A4-A8E7-2CBA4C5DC7AEQ33740847-C1F5CEB7-145B-42B6-93C9-776119E22B8CQ33748553-C94AB22E-7D64-45B4-83A7-2F47C0ECBDE3Q33905411-1306C60E-1A63-43A1-9E04-2F787BE485CAQ34013562-905B7B0C-414A-41E6-8BBE-162A8AA4DAE2Q34044387-6410EE52-17FE-47B6-8A67-B5EFC898E10EQ34063315-C0DC0B2D-0534-436F-BD13-73E2A67BFC9BQ34106843-178F49BA-C475-491A-8906-7BBEB7653F07Q34164140-808389CB-4DB9-4F13-82CA-B3191BB322E8Q34294123-645F1261-4FFF-4614-8D59-EAD1F93CA0D0Q34503563-F65BE894-FE67-48BC-ABCA-D0CEF8CE042FQ34707338-20270EC7-B0BC-4A1F-A299-07B6AA8E799DQ34755738-69DE1948-B490-4337-9B2D-87669CFC51DAQ34813171-8A3E03DB-652C-4AF3-BA2A-875B2CF7A274Q34831296-A26340E8-7419-4104-B0DD-3F2DF2EC5DA5Q34854165-CDA934C5-C45F-410C-B1BC-F3CD3DA49B3BQ34909225-15228F1A-CE8C-42B0-A57D-C651A3C55DEEQ34974448-1FCEB6CF-552F-414C-A85D-268FEC5B0803Q35105055-01723415-9A09-4A84-9DEA-C61773E4A1D2Q35110486-EF30BCF0-049A-4B2C-B117-8881CA83F1C9Q35187089-6634CB0A-4567-4771-9F37-470F54F32D0CQ35432158-8D0698E7-2C4B-49B3-A13E-6F62CB514F1FQ35616110-7A02CEA3-2362-440C-9ED4-A4281F5A6109Q35680023-B83BC6CE-4FE9-4AB9-9E91-58F3DC91C8F6Q35799028-8688CC5E-E755-421E-B00C-D73A070A34E0Q35816029-7E49DBD6-D374-4634-9A38-CE40E4CEFB20Q35840704-67D4C4CF-2796-40E3-88DD-DE8D96405C21Q35842405-D0A53D8B-3CFA-4EC5-8C48-08B27CEED7CDQ35862322-DF40C60B-0546-458A-96DA-7FBB31F13D3CQ35889002-8919C46D-99E7-4188-82D3-8FCA560CC9F1
P2860
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@ast
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@en
type
label
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@ast
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@en
prefLabel
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@ast
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@en
P2093
P2860
P356
P1476
Therapeutic B cell depletion i ...... CD4+ T cell activation in mice
@en
P2093
Guglielmo M Venturi
Jean-David Bouaziz
Jonathan C Poe
Koichi Yanaba
Roland M Tisch
Thomas F Tedder
Yaming Wang
P2860
P304
20878-20883
P356
10.1073/PNAS.0709205105
P407
P577
2007-12-19T00:00:00Z